Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9BGJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,638
Award facts
- Contract value 100% obligated
- $8,637.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded December 11, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Zepbound (tirzepatide) 10 mg/0.5 mL in pre-filled pen format with a contract ceiling value of $8,637.98. The award is non-competitive and represents a firm fixed-price delivery order with an ultimate completion date of December 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. As a major pharmaceutical distributor and critical federal medical vendor, the company holds a significant indefinite delivery contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the vehicle enabling this and similar pharmaceutical deliveries across the federal healthcare system.
This delivery order falls under AmerisourceBergen Drug Corp's broader pharmaceutical supply mission supporting military and veteran healthcare systems. The award of Zepbound, a diabetes medication, aligns with the company's extensive portfolio of specialty pharmaceutical products delivered through the DLA Medical Supply Chain to support Defense Health Agency operations and other federal healthcare customers. The delivery order structure and firm fixed pricing reflect typical DLA procurement practices for medical commodities, enabling rapid fulfillment of critical pharmaceutical needs for federal healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F9BGJ?
SPE2DR26F9BGJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F9BGJ worth?
The government has obligated $8,638 on SPE2DR26F9BGJ.
Is contract SPE2DR26F9BGJ an order under another contract?
Yes. SPE2DR26F9BGJ is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9BGJ competed?
The extent of competition for SPE2DR26F9BGJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award